Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study
Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W · 1994 · Clinical neuropharmacology
What does this source report?
A 12-week placebo comparison reported an aphasia signal but no demonstrated improvement in activities of daily living. Persistence at 24 weeks was unresolved.
- Population and setting
- 158 post-stroke rehabilitation patients; 137 assessed after treatment and 88 at 24 weeks
- Evidence type
- Randomized trial
- Preparation
- See the original report; formulation details require verification.
- Source language
- See linked publication
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Substantial loss to later follow-up limits interpretation.
- Aphasia findings require confirmation and do not establish healthy-person cognitive enhancement.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Journal article
Review depth: Abstract
Source access and review scope
Europe PMC indexed abstract checked; complete trial methods not reviewed.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study Clinical neuropharmacology 1994.
Molekul research summary: https://molekul.io/research/piracetam-9316679. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry